SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,758 | +4.8% | 97 | -1.0% | 0.00% | 0.0% |
Q2 2023 | $11,223 | -16.9% | 98 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $13,507 | +5.3% | 98 | -1.0% | 0.00% | 0.0% |
Q4 2022 | $12,828 | +16.6% | 99 | +1.0% | 0.00% | 0.0% |
Q3 2022 | $11,000 | +57.1% | 98 | 0.0% | 0.00% | +100.0% |
Q2 2022 | $7,000 | -41.7% | 98 | -37.6% | 0.00% | -50.0% |
Q1 2022 | $12,000 | -29.4% | 157 | -18.2% | 0.00% | -33.3% |
Q4 2021 | $17,000 | +6.2% | 192 | +12.3% | 0.00% | 0.0% |
Q3 2021 | $16,000 | +128.6% | 171 | +87.9% | 0.00% | +200.0% |
Q2 2021 | $7,000 | +600.0% | 91 | +1200.0% | 0.00% | – |
Q1 2021 | $1,000 | -96.9% | 7 | -96.3% | 0.00% | -100.0% |
Q4 2020 | $32,000 | +540.0% | 190 | +387.2% | 0.00% | +300.0% |
Q3 2020 | $5,000 | -16.7% | 39 | +8.3% | 0.00% | -50.0% |
Q2 2020 | $6,000 | +200.0% | 36 | +111.8% | 0.00% | +100.0% |
Q1 2020 | $2,000 | 0.0% | 17 | +41.7% | 0.00% | 0.0% |
Q4 2019 | $2,000 | +100.0% | 12 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | -50.0% | 12 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $2,000 | 0.0% | 12 | -7.7% | 0.00% | 0.0% |
Q1 2019 | $2,000 | +100.0% | 13 | +160.0% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 5 | 0.0% | 0.00% | – |
Q2 2018 | $1,000 | – | 5 | 0.0% | 0.00% | – |
Q1 2018 | $0 | – | 5 | 0.0% | 0.00% | – |
Q4 2017 | $0 | – | 5 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |